SeminarPast EventNeuroscience

Desarrollo de tratamientos para síndromes de epilepsia: oportunidades para SYNGAP1

Ana Mingorance PhD

Dracaena Consulting / Fundación Loulou (España)

Schedule

Friday, February 19, 2021

Showing your local timezone

Schedule

Friday, February 19, 2021

12:30 AM America/Bogota

Host: SYNGAP by SRF

Event Information

Domain

Neuroscience

Host

SYNGAP by SRF

About the Speaker

Ana Mingorance PhD

Dracaena Consulting / Fundación Loulou (España)

Contact & Resources

Personal Website

es.syngapresearchfund.org/post/unase-a-nosotros-a-el-primer-congreso-cientifico-virtual-syngap1-en-espanol

Related Seminars

Seminar60%

Investigating the Neurobiology and Neurophysiology of Psilocybin Using Drosophila melanogaster as a Model System

neuro

Jun 4, 2025

Acadia University

Seminar60%

Expanding mechanisms and therapeutic targets for neurodegenerative disease

neuro

A hallmark pathological feature of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the depletion of RNA-binding protein TDP-43 from the nucleus

Jun 4, 2025

Department of Genetics, Stanford University

Seminar60%

The Direct Impact Of Amyloid-Beta Oligomers On Neuronal Activity And Neurotransmitter Releases On In Vivo Analysis

neuro

Jun 4, 2025

Université de Montréal

Desarrollo de tratamientos para síndromes de epilepsia: oportunidades para SYNGAP1

Event Information

Topics

About the Speaker

Related Seminars

Investigating the Neurobiology and Neurophysiology of Psilocybin Using Drosophila melanogaster as a Model System

Expanding mechanisms and therapeutic targets for neurodegenerative disease

The Direct Impact Of Amyloid-Beta Oligomers On Neuronal Activity And Neurotransmitter Releases On In Vivo Analysis